search
subscribe by email
Twitter
-
Recent Posts
current comments
topics
- #RunningAtlas (1)
- Atlas Venture (27)
- Bioentrepreneurship (18)
- Biotech financing (62)
- Biotech investment themes (32)
- Biotech startup advice (45)
- Boards and governance (3)
- Boston Cluster (13)
- Business Development (23)
- Capital efficiency (19)
- Capital markets (10)
- Corporate Culture (13)
- Diagnostics (2)
- Drug discovery (12)
- Exits IPOs M&As (94)
- External R&D (10)
- FDA (1)
- From The Trenches (105)
- Fundraising (4)
- General Venture Capital (43)
- Governance (2)
- New business models (28)
- Patients (5)
- Personalized Medicine (4)
- Pharma industry (57)
- Portfolio news (45)
- R&D Productivity (13)
- Rare Diseases (5)
- Science & Medicine (15)
- Talent (22)
- The Human Element (1)
- Translational research (34)
- Uncategorized (21)
- VC-backed Biotech Returns (64)
monthly archive
- April 2018 (3)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (3)
- November 2017 (4)
- October 2017 (6)
- September 2017 (4)
- August 2017 (2)
- July 2017 (1)
- June 2017 (5)
- May 2017 (4)
- April 2017 (1)
- March 2017 (5)
- February 2017 (2)
- January 2017 (7)
- December 2016 (3)
- November 2016 (4)
- October 2016 (3)
- September 2016 (6)
- August 2016 (5)
- July 2016 (3)
- June 2016 (6)
- May 2016 (5)
- April 2016 (4)
- March 2016 (7)
- February 2016 (5)
- January 2016 (6)
- December 2015 (6)
- November 2015 (3)
- October 2015 (4)
- September 2015 (5)
- August 2015 (3)
- July 2015 (3)
- June 2015 (4)
- May 2015 (6)
- April 2015 (6)
- March 2015 (7)
- February 2015 (7)
- January 2015 (5)
- December 2014 (4)
- November 2014 (3)
- October 2014 (7)
- September 2014 (5)
- August 2014 (5)
- July 2014 (4)
- June 2014 (6)
- May 2014 (5)
- April 2014 (5)
- March 2014 (6)
- February 2014 (4)
- January 2014 (5)
- December 2013 (3)
- November 2013 (2)
- October 2013 (4)
- September 2013 (3)
- August 2013 (1)
- July 2013 (2)
- June 2013 (2)
- May 2013 (4)
- April 2013 (2)
- March 2013 (4)
- February 2013 (1)
- January 2013 (3)
- December 2012 (3)
- November 2012 (4)
- October 2012 (3)
- September 2012 (4)
- August 2012 (3)
- July 2012 (3)
- June 2012 (4)
- May 2012 (3)
- April 2012 (2)
- March 2012 (3)
- February 2012 (3)
- January 2012 (6)
- December 2011 (4)
- November 2011 (4)
- October 2011 (3)
- September 2011 (4)
- August 2011 (3)
- July 2011 (4)
- June 2011 (4)
- May 2011 (5)
- April 2011 (8)
- March 2011 (10)
Tag Archives: neuropathic pain
Painful Truth: Successful Failure Of A Biotech Startup
November 17, 2017
Back in the summer, I got the call that no biotech venture investor wants to get. On the morning of August 8th, I received an urgent text of “can you talk now?” quickly followed with a call. I learned then
Soothing Chronic Pain: Quartet’s Debut
October 23, 2014
This blog was written by Kevin Pojasek, co-founder, President, and acting CEO of Quartet Medicine, as part of the “From the Trenches” feature of LifeSciVC. Addressing unmet need in chronic pain In the mid-1990’s, the American Pain Society and the Veterans